Chicago Classification Normative Metrics in a Healthy Russian Cohort According to High-resolution Esophageal Manometry
NCT ID: NCT03829865
Last Updated: 2021-04-26
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
80 participants
OBSERVATIONAL
2019-02-04
2023-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Diagnostic Evaluation of Esophageal Motility Disorders Using the Chicago IV Protocol in Egypt
NCT06878586
Normal Values for Esophageal High Resolution Manometry in an Advanced Protocol Including Liquid Swallows and a Solid Test Meal
NCT02407938
Establishing Pressures at the EGJ During Diaphragmatic Breathing Using High-resolution Esophageal Manometry
NCT06329583
Esophageal Impedance and Manometry Measurements and Dysphagia Symptom Scoring
NCT04503785
Validation of HRM Score for the GERD Diagnosis
NCT05851482
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Water-perfused HREM
Healthy volunteers examined with water-perfused high resolution esophageal manometry
High resolution esophageal manometry
High resolution esophageal manometry will be performed to eligible subjects willing to participate in the study
Solid-state HREM
Healthy volunteers examined with high resolution esophageal manometry with solid-state catheter
High resolution esophageal manometry
High resolution esophageal manometry will be performed to eligible subjects willing to participate in the study
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
High resolution esophageal manometry
High resolution esophageal manometry will be performed to eligible subjects willing to participate in the study
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Patients of both sexes, aged 18 to 65 years inclusive;
* Permanent residence in the Russian Federation;
* Absence of esophageal diseases, confirmed by the results of clinical and instrumental examination
* Ability to follow instructions during high-resolution esophageal manometry procedure
Exclusion Criteria
* any surgical intervention on the gastrointestinal tract and / or chest organs in medical history;
* solid organ transplantation in medical history with the exception of a corneal transplant and surgery to replace the lens of the eye;
* any oncology of any localization except for skin cancer in situ in the medical history;
* any decompensated diseases of any organs and systems, which, in the opinion of the researcher, makes it impossible to carry out the procedure of esophageal manometry of high resolution or if the procedure may cause the risk of deterioration of the patient's condition;
* any condition, clinical and laboratory signs of alcohol abuse (abuse will be assessed in the case of male subjects consuming more than 30 g of pure alcohol per day and using more than 20 g of pure alcohol per day by female subjects;
* any illegal drug use, current or past;
* use of concomitant medications that can affect esophageal motility including, but not limited to: calcium channel blockers, metoclopramide, m-cholinolytics, domperidone, erythromycin, nitrates, tricyclic antidepressants, opiates, beta-blockers, beta-adrenomimetics, alcohol. The duration of the period of non-use of these drugs should provide sufficient time for the complete cessation of their pharmacological action, but not less than two half-life.
* pregnant or breastfeeding women
* any condition making impossible to perform high resolution esophageal manometry (previously known poor tolerability of the procedure; narrow nasal passages; significant curvature of the nasal septum etc).
18 Years
65 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Russian Academy of Medical Sciences
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Vasily Isakov
MD, PhD, Professor, AGAF
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Vasily Isakov, MD, PhD
Role: STUDY_CHAIR
Federal Research Center of Nutrition and Biotechnology
Sergey Morozov, MD, PhD
Role: PRINCIPAL_INVESTIGATOR
Federal Research Center of Nutrition and Biotechnology
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Gastroenterology and Hepatology, FRC Nutrition and Biotechnology
Moscow, , Russia
Moscow clinical hospital #31
Moscow, , Russia
Pavlov First Saint Petersburg State Medical University. Endoscopy Department
Saint Petersburg, , Russia
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
OGIG-2019-1
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.